apollo
logo
0Login
Introducing Our Latest Arrival!
Pamorelin LA 11.25 mg Injection

Pamorelin LA 11.25 mg Injection

Consult Doctor
Prescription drug
 Trailing icon

Manufacturer/Marketer

Dr. Reddy'S Laboratories Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Apr-24

for this medicine

About Pamorelin LA 11.25 mg Injection

Pamorelin LA 11.25 mg Injection belongs to the class of 'anti-neoplastic agents', primarily used to treat prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Prostate cancer is the prostate gland's cancer (a small gland under the bladder secretes fluid that nourishes and protects sperm) found only in men. Endometriosis is a disorder in which tissue lining the uterus grows outside the uterine cavity. Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon.

Pamorelin LA 11.25 mg Injection contains Triptorelin that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. Triptorelin is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. The lowering of testosterone hormone levels in men helps slows down the growth of cancer cells in prostate cancer.

Use Pamorelin LA 11.25 mg Injection as prescribed by your doctor. Your doctor will decide the dosage depending on your medical condition. The common side effects of Pamorelin LA 11.25 mg Injection include hot flashes, decreased sexual interest, shrinking of the testicles, breast tenderness or swelling, dizziness, headache, flu symptoms, nausea, vomiting, diarrhoea, upset stomach and swelling in legs. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Do not take or stop this medicine, if the doctor did not advise you to do so. Before starting Pamorelin LA 11.25 mg Injection, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Pamorelin LA 11.25 mg Injection is not indicated for use in pregnant and breastfeeding women. Pamorelin LA 11.25 mg Injection may make you feel dizzy, hence drive when you are alert only. Pamorelin LA 11.25 mg Injection is not recommended for children below two years of age.

Uses of Pamorelin LA 11.25 mg Injection

Prostate cancer, endometriosis and precocious puberty.

Medicinal Benefits

Pamorelin LA 11.25 mg Injection contains Triptorelin, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Pamorelin LA 11.25 mg Injection is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Being an anti-neoplastic or anticancer agent, Pamorelin LA 11.25 mg Injection works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Pamorelin LA 11.25 mg Injection reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helps in shrinking of endometriosis. Pamorelin LA 11.25 mg Injection also has the role of a contraceptive drug.

Directions for Use

It will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Pamorelin LA 11.25 mg Injection

  • Hot flashes
  • Decreased sexual interest
  • Shrinking of the testicles
  • Breast tenderness or swelling
  • Dizziness
  • Headache
  • Flu 
  • Nausea
  • Vomiting
  • Diarrhoea
  • Upset stomach
  • Swelling in legs 

Drug Warnings

Inform your doctor if you have any allergic reactions to Pamorelin LA 11.25 mg Injection or other medications. Before starting Pamorelin LA 11.25 mg Injection, let your doctor know if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Pamorelin LA 11.25 mg Injection may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Pamorelin LA 11.25 mg Injection. Pamorelin LA 11.25 mg Injection can affect the unborn baby when used in pregnancy. Hence, Pamorelin LA 11.25 mg Injection is not indicated for use in pregnancy and breastfeeding women. If you are using Pamorelin LA 11.25 mg Injection, make sure to use reliable forms of contraception to prevent pregnancy during the course. Pamorelin LA 11.25 mg Injection may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Pamorelin LA 11.25 mg Injection can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused. Pamorelin LA 11.25 mg Injection is not recommended for children younger than two years of age.

Drug Interactions

Drug-Drug Interaction: Pamorelin LA 11.25 mg Injection may interact with heart rhythm problems treating drugs (quinidine, procainamide, amiodarone, sotalol), antibiotics (moxifloxacin), opioid pain killers (methadone) and antipsychotics.

Drug-Food Interaction: No interactions found/established.

Drug-Disease Interaction: Pamorelin LA 11.25 mg Injection should be used with caution in cases of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels.

Drug-Drug Interactions Checker List

  • QUINIDINE
  • PROCAINAMIDE
  • AMIODARONE
  • SOTALOL
  • MOXIFLOXACIN
  • METHADONE

Habit Forming

No

Diet & Lifestyle Advise

  • Take the medication as directed by the doctor and at regular intervals. 
  • Maintain a fibre-rich diet and include healthy carbohydrates from fruits, vegetables and whole grains.
  • Include fish, soy, tomatoes, Brussels sprouts, kale, broccoli and oils containing omega-3 fatty acids such as olive oil as these foods may reduce the risk of prostate cancer.
  • Avoid grilled meat, red meat, saturated fat found in animal products, milk and dairy products.
  • Exercise regularly to lose weight as obesity is also considered as a risk factor for prostate cancer.
  • Eat at regular intervals.
  • Keep your weight under control with BMI 19.5-24.9.
  • Opt for a diet rich in whole grains, fruits, veggies and low-fat dairy products.

Special Advise

  • Your doctor may advise liver function tests to monitor your liver health since Pamorelin LA 11.25 mg Injection may cause increased liver enzymes (alanine aminotransferase, serum aspartate and serum transaminases).
  • Pamorelin LA 11.25 mg Injection may cause increased serum glucose levels (hyperglycaemia), hence inform your doctor if you have diabetes before starting Pamorelin LA 11.25 mg Injection.
  • Your doctor may advise blood tests and regular examinations of the prostate.
  • It is advised to get an electrocardiogram (ECG) done timely to monitor your heart health.

Disease/Condition Glossary

Prostate cancer: It is the cancer of the prostate gland (a small gland under the bladder that secretes fluid that nourishes and protects sperm) found only in men. The symptoms include difficulty in urination, pain, numbness or sexual problems. It is the most common type of cancer in men.

Endometriosis: It is a disorder in which tissue lining the uterus grows outside the uterine cavity. It commonly involves ovaries, fallopian tubes and the tissue lining the pelvis. Symptoms of endometriosis include pain and irregular periods.

Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon. If puberty begins before age 8 in girls and before age 9 in boys, it is considered precocious puberty. Symptoms in a girl include first period and breast development, whereas, in boy, it causes enlarged testicles and penis,  deepening voice and facial hair.

Country of origin

India

Manufacturer/Marketer address

Dr. Reddy's Laboratories Ltd., 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, INDIA
Other Info - PAM0202

FAQs

Pamorelin LA 11.25 mg Injection contains Triptorelin, a synthetic hormone. It helps reduce the testosterone and oestrogen hormones in men and women, respectively. This process of lowering hormone levels can decrease cancer cell's growth in prostate cancer in men and shrinks endometriosis in women.
Take the missed dose as soon as possible. However, if it is time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose.
Pamorelin LA 11.25 mg Injection should be used with caution and under doctor's supervision only if you have any medical history of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Let your doctor know if you have any other medical concerns before using Pamorelin LA 11.25 mg Injection.
During treatment with Pamorelin LA 11.25 mg Injection in the first few weeks, a temporary increase in hormones may occur before they decrease. This may cause new or worsening of side effects of Pamorelin LA 11.25 mg Injection. This is a normal response of your body to Pamorelin LA 11.25 mg Injection. However, if you notice any symptoms that are not manageable, please seek medical advice.
Pamorelin LA 11.25 mg Injection may worsen your mood disorders like depression. Hence it is advised to use Pamorelin LA 11.25 mg Injection only when you are free from any kind of mental problems. Please consult your doctor for more information.
Pamorelin LA 11.25 mg Injection may cause impotence and affect fertility in men. It is advised to speak to your doctor if you plan to have a family in the future before starting Pamorelin LA 11.25 mg Injection.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Caution

It is advised to avoid alcohol consumption to minimize the unwanted effects of Pamorelin LA 11.25 mg Injection. Please consult your doctor for more information.

bannner image

Pregnancy

Unsafe

Pamorelin LA 11.25 mg Injection is a pregnancy category X drug. It is unsafe to use Pamorelin LA 11.25 mg Injection in pregnancy and can have harmful effects on the unborn baby. Use reliable forms of contraception to prevent pregnancy while using Pamorelin LA 11.25 mg Injection.

bannner image

Breast Feeding

Unsafe

Pamorelin LA 11.25 mg Injection is unsafe to use during breastfeeding. Consult your doctor for further information.

bannner image

Driving

Unsafe

Pamorelin LA 11.25 mg Injection causes dizziness and affects your ability to drive. Do not drive or operate machinery if you experience any unmanageable side effects with Pamorelin LA 11.25 mg Injection.

bannner image

Liver

Caution

Please let your doctor know if you have any history of liver diseases or hepatic impairment before starting Pamorelin LA 11.25 mg Injection.

bannner image

Kidney

Caution

Please let your doctor know if you have any history of kidney diseases before starting Pamorelin LA 11.25 mg Injection.

bannner image

Children

Caution

Pamorelin LA 11.25 mg Injection is not recommended in children younger than two years of age.

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

Add to Cart